阿维A治疗多发性难治性疣的临床观察.pdfVIP

论　　著 Lunzhu　　《中外医学研究》第 13 卷 第 11 期（总第 271 期）2015 年 4月 阿维A治疗多发性难治性疣的临床观察 ① ② 　 刘扬波 　陈尧 【摘要】　目的： 方法： 　　 观察阿维 A 治疗难治性多发性疣的临床疗效和安全性。 选取笔者所在科室 2012 年 1 月 -2014 年 8 月就诊的 83 例多发性难治性疣患者作为研究对象，口服阿维 A 胶囊 20~30 mg/d 治疗，疗程 8 周，观察疗效情况和安全性。结果：阿维 A 治疗多种多 发性难治性疣 ( 包括多发扁平疣、多发跖疣、多发甲周寻常疣、多发尖锐湿疣等 ) 有效率达到 89.16%，痊愈率达到 74.70%，且未见发生严 重和永久性不良反应。结论：阿维 A 治疗多种多发性难治性疣疗效显著且安全性好，为不适合选择其他方法或其他方法治疗效果差的多种 多发性难治性疣患者提供了新的选择，值得临床推广应用。 【关键词】 　　 　阿维 A；　多发性难治性疣；　疗效观察 　　中图分类号　R752.5 文献标识码　A 文章编号　1674-6805(2015)11-0008-02 　　Clinical Observation of Avermectin A in the Treatment of Multiple Refractory Warts/LIU Yang-bo，CHEN Yao.//Chinese and Foreign Medical Research，2015，13(11)：8-9 　　【Abstract】　Objective：To observe the clinical efficacy and safety of Avermectin A in the treatment of multiple refractory warts.Method：83 patients with multiple refractory warts in our department from January 2012 to August 2014 were selected as research objects，they were treated by oral Acitretin Capsules，20-30 mg/day for 8 weeks.The efficacy and safety of treatment were observed.Result：The treatment efficiency and the recovery rate of avermectin A on multiple refractory warts including multiple verruca plana，multiple verruca plantaris，multiple periungual warts and multiple condyloma acuminatum were 89.16% and 74.70% respectively，and no severe or permanent adverse reactions were observed.Conclusion：Treatment on multiple refractory warts by Avermectin A has a remarkable efficacy and safety，which can provide alterative treatment for many refractory multiple warts that were difficult to be cured by other traditional methods，and the present treatment was suitable for popular application in